Skip to content

Insider · CIK 0001670431

Eduardo Bruno Martins

officer

Files at SGMT (Sagimet Biosciences Inc.). First filing Jul 23, 2025, latest Feb 12, 2026.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $95k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

SGMT: Sagimet Biosciences Inc.

SGMTOct 9, 2026 · close 8.93

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
SGMTsell 3
Sagimet Biosciences Inc.
$20k
3,640 shares
-3%+197% from low-45% from high
38Weak
SGMTsell 3
Sagimet Biosciences Inc.
$76k
8,277 shares
-7%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Feb 19, 2026SGMT
Sagimet Biosciences Inc.
AGrant or award
Series A Common Stock
+44,000$0.00$0147,296Feb 20, 2026
Feb 19, 2026SGMT
Sagimet Biosciences Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+88,000$0.00$088,000Feb 20, 2026
Feb 10, 2026SGMT
Sagimet Biosciences Inc.
SOpen-market sale
Series A Common Stock
-3,640$5.36$20k103,296Feb 12, 2026
Jul 21, 2025SGMT
Sagimet Biosciences Inc.
SOpen-market sale
Series A Common Stock
-8,277$9.13$76k106,936Jul 23, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Eduardo Bruno Martins: insider trades and track record | InsiderTell